GEODE CAPITAL MANAGEMENT, LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 26 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$6,000
-14.3%
27,1560.0%0.00%
Q2 2020$7,000
+40.0%
27,1560.0%0.00%
Q1 2020$5,000
-80.8%
27,156
-50.0%
0.00%
Q4 2019$26,000
+36.8%
54,312
+100.0%
0.00%
Q3 2019$19,000
-83.8%
27,1560.0%0.00%
Q2 2019$117,000
-7.9%
27,156
+56.6%
0.00%
Q1 2019$127,000
-51.2%
17,341
-50.0%
0.00%
Q4 2018$260,000
+168.0%
34,682
+100.0%
0.00%
Q3 2018$97,000
+76.4%
17,341
+37.3%
0.00%
Q2 2018$55,00012,6310.00%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 809,804$4,140,0000.60%
SABBY MANAGEMENT, LLC 514,878$2,652,0000.14%
Migdal Insurance & Financial Holdings Ltd. 497,200$2,542,0000.06%
Renaissance Technologies 12,944$66,0000.00%
DEUTSCHE BANK AG\ 12,724$65,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders